Synthace Announces Appointment of Willem Baralt as New Chairman

07.08.2025 - 18:07:26

Synthace Massachusetts United States of America United Kingdom England

addresses the fragmented laboratory R&D landscape in life science companies. It is designed to enhance the reliability of experimental data by supporting scientists through automation across various stages, including experimental design, simulations, analyses, and the creation of comprehensive digital records for each experiment.

"We welcome Willem Baralt's appointment as Chairman of the Board," said Joe Anderson, PhD, Partner at Sofinnova Partners. "Willem's extensive experience in driving commercial growth and fostering innovation makes him a valuable addition to the leadership team and will bolster Synthace's potential to bring groundbreaking advancements to laboratory R&D."

About Synthace
Headquartered in London, UK, and Boston, USA, Synthace is a cloud-based experiment platform transforming life science R&D. By automating high-throughput experiments, structuring complex datasets, and integrating methodologies like Design of Experiments, Synthace enables scientists to innovate faster and tackle humanity's most pressing challenges.

The platform digitizes experiments end-to-end, allowing scientists to design, plan, and simulate reproducible experiments with minimal training. Operated from a browser window without needing code, it simplifies lab operations, enhances scientific value, and enables experiments previously deemed impossible. This allows scientists to focus on addressing critical questions, driving scientific progress, and advancing solutions to humanity's most pressing problems.

Media contact:
YourStory PR
Courtney@yourstorypr.com
+44(0)7867488769

Photo - https://mma.prnewswire.com/media/2366155/Synthace_1.jpg
Logo - https://mma.prnewswire.com/media/2366154/Synthace_Logo.jpg